It's unclear if the new subvariant causes any unfamiliar symptoms that haven't already been documented by other Omicron subvariants.
Thankfully, the rates of anosmia and ageusia seem to be dropping.
It's unclear if the new subvariant causes any unfamiliar symptoms that haven't already been documented by other Omicron subvariants.
Thankfully, the rates of anosmia and ageusia seem to be dropping.